Yes, Duane, I'll start - I'll actually start with the second part, which is the reasoning. First of all, since April we've had the ability to call the convert and I think that our calculus is that at this time the economics of the deal worked out for us versus letting it mature. And then thirdly, I would say the Board when it made its decision, they simply - I think, they wanted to get the pandemic behind us and I think that also influence the decision even though, as I mentioned before, from an economic perspective and financial perspective, it made sense for us to execute the call at this time even with a make-whole affected, et cetera. I would say that the - in terms of the accounting-wise - first of all, we're electing to settle it via the net share method, whereby we will pay that principal in cash, $350 million in cash and the remainder in shares, that - ultimately the valuation of that will depend on a 40 day - 40 trading day observation period that ends in the second week in September. So that will ultimately determine what - ultimately what the number of issued shares that we would have coming out at that time, the day of the settlement. So that's still pending to be determined. And then finally, in terms of how it affects the interest expense, the interest expense will go down by two factors. Number one, of course, the coupon goes away, the 4.5% coupon on the $350 million, but in addition to that, there is a portion, I'll say, maybe it's about a $7 million per quarter figure that was a portion of our interest expense that was non-cash, that will basically go away during - after the settlement. So that's basically the way that it will work out.